Elodie obtained her Master’s degree in Physiology, Physiopatholoy and Neurosciences at Lille 2 University in 2007. Then she joined the Blood-Brain Barrier Laboratory (LBHE, EA2465, Artois University) to prepare a PhD in Life Sciences that she defended in 2011: her project was dealing with the development of new in vitro blood-brain barrier (BBB) models for the study of cellular interactions in health and disease.

A first postdoctoral position in Mannheim Children’s Hospital (Germany, 2012-2013) allowed her to work on neuroblastoma brain metastasis. Back to France she worked on different topics using cellular models, from breast cancer brain metastasis (2014-2015) to the impact of ischemia on BBB cells (2016-2017), making her an expert in cell biology and complex in vitro systems.

She’s recently joined us as a study director!


We are very happy to present you Pierre-Jean Ferron, who joined HCS Pharma as a study director, specialized in cellular biology and high content analysis.

After a master degree in cellular biology and cellular toxicology at Rennes University, Pierre-Jean realized a Ph.D at the Frenh Agency for Food and Safety. During his Ph.D Pierre-Jean has developped high content toxicology assay, based on the use of pertinent cell lines models to study human cytotoxicity of phycotoxins. He then began a post doc in collaboration with the French Institute for Agricultural Research where he studied the toxicological impact of meat contaminants on human cells. For those years, Pierre-Jean has developped strong knowledge in cellular biology and high content analysis, and published several scientific papers.